Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06520293
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-21
Brief Title:
Effects of a Single Oral Dose of Sweet Protein Sweelin on Blood Glucose and Insulin Levels in Healthy Adults
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effects of a Single Oral Dose of Sweet Protein Sweelin on Blood Glucose and Insulin Levels in Healthy Adults a Crossover Double Blinded Clinical Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study aims to evaluate for the first time the post-prandial effects of a single oral administration of Serendipity Berry Sweet Protein sweelin compared to glucose and stevia as a commercial sweetener in healthy adults The study design is a single center randomized crossover study
Each subject will receive a single oral dose of sweelin compared with an equivalently sweet dose of glucose and stevia dissolved in a water beverage with flavor
The advantage of a crossover design is that it will allow to compare the blood glucose and insulin levels of each subject to his baseline in every test beverage and to remove the inter-subject variability The post-prandial effects will be monitored with multiple blood sampling up to 120 minutes post dosing
Each subject will receive a single oral dose of sweelin compared with an equivalently sweet dose of glucose and stevia dissolved in a water beverage with flavor
The advantage of a crossover design is that it will allow to compare the blood glucose and insulin levels of each subject to his baseline in every test beverage and to remove the inter-subject variability The post-prandial effects will be monitored with multiple blood sampling up to 120 minutes post dosing
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None